(Q35597348)

9 August 2017

title

Risk of haematopoietic cancer in patients with inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

9 August 2017

main subject

0 references

0 references

7

A Ekbom

1 reference

9 August 2017

J Askling

1

1 reference

9 August 2017

L Brandt

2

1 reference

9 August 2017

A Lapidus

3

1 reference

9 August 2017

P Karlén

4

1 reference

9 August 2017

M Björkholm

5

1 reference

9 August 2017

R Löfberg

6

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

9 August 2017

1 reference

9 August 2017

volume

54

1 reference

9 August 2017

issue

5

1 reference

9 August 2017

page(s)

617-622

1 reference

Infliximab in inflammatory bowel disease: clinical outcome in a population based cohort from Stockholm County

9 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Balancing the risks and benefits of infliximab in the treatment of inflammatory bowel disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Review article: does the use of immunosuppressive therapy in inflammatory bowel disease increase the risk of developing lymphoma?

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

The incidence of lymphoid and myeloid malignancies among hospitalized Crohn's disease patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Risk of lymphoma in inflammatory bowel disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Increased incidence of non-Hodgkin's lymphoma in inflammatory bowel disease patients on immunosuppressive therapy but overall risk is low

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Increased risk of cancer in ulcerative colitis: a population-based cohort study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

General and cancer specific mortality of a population based cohort of patients with inflammatory bowel disease: the Florence Study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Incidence of Crohn's disease in Stockholm County 1955-1989.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Intestinal cancer risk and mortality in patients with Crohn's disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Cancer in patients with ulcerative colitis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Malignancy in Crohn's disease

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Cancer morbidity in ulcerative colitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Colorectal and extracolonic malignancy in ulcerative colitis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Inflammatory bowel disease and leukemia. A report of seven cases of leukemia in ulcerative colitis and Crohn's disease and review of the literature

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Statistical methods in cancer research. Volume II--The design and analysis of cohort studies

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Colonoscopic surveillance in long-standing total ulcerative colitis--a 15-year follow-up study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Extracolonic malignancies in inflammatory bowel disease.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Hodgkin's disease risk is increased in patients with ulcerative colitis.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Crohn's disease and cancer risk (Denmark).

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Concurrent inflammatory bowel disease and myelodysplastic syndromes

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

The association of inflammatory bowel disease and leukemia--coincidence or not?

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

The person-number systems of Sweden, Norway, Denmark, and Israel.

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives

26 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Lymphoma risk in inflammatory bowel disease: influences of referral bias and therapy.

15 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Review article: the risk of lymphoma associated with inflammatory bowel disease and immunosuppressive treatment

15 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1774486

Extraintestinal cancers in inflammatory bowel disease

15 November 2018

1 reference

12 December 2020

Long-term neoplasia risk after azathioprine treatment in inflammatory bowel disease

1 reference

12 December 2020

Crohn's disease and cancer: a population-based cohort study

1 reference

12 December 2020

Survival and cause-specific mortality in inflammatory bowel disease: a population-based cohort study

1 reference

12 December 2020

Acute myeloblastic leukemia following prolonged treatment of Crohn's disease with 6-mercaptopurine

1 reference

12 December 2020

Inflammatory bowel disease and leukemia

1 reference

12 December 2020

Cancer risk in patients with inflammatory bowel disease: a population-based study

1 reference

12 December 2020

Inflammatory bowel disease is not associated with an increased risk of lymphoma

1 reference

12 December 2020

Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration

1 reference

12 December 2020

Acute myelogenous leukemia in patients with ulcerative colitis

1 reference

12 December 2020

Identifiers

DOI

10.1136/GUT.2004.051771

1 reference

9 August 2017

1 reference

9 August 2017

1 reference